Home > Insider Trading > Filing (0001181431-10-055850)

Filing Details

Accession Number:: 0001181431-10-055850
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-16 14:00:01
Reporting Period:: 2010-11-16

Filing Date:: 2010-11-16
Accepted Time:: 2010-11-16 14:00:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1361103	Complete Genomics Inc	GNOM	Services-Commercial Physical & Biological Research (8731)	203226545

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1428991	Essex Woodlands Health Ventures Fund Viii-A Lp	C/O Essex Woodlands Health Ventures 21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	Yes	No
1428992	Essex Woodlands Health Ventures Fund Viii Lp	C/O Essex Woodlands Health Ventures 21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	Yes	No
1452935	Essex Woodlands Health Ventures Fund Viii-B Lp	C/O Essex Woodlands Health Ventures 21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2010-11-16	2,061,134	$0.00	2,061,134	No	4	C	Indirect	See Footnote
Common Stock, Par Value $0.001	Acquisiton	2010-11-16	1,159,218	$0.00	3,220,352	No	4	C	Indirect	See Footnote
Common Stock, Par Value $0.001	Acquisiton	2010-11-16	546,268	$9.00	3,766,620	No	4	P	Indirect	See Footnote
Common Stock, Par Value $0.001	Acquisiton	2010-11-16	148,608	$0.00	148,608	No	4	C	Indirect	See Footnote
Common Stock, Par Value $0.001	Acquisiton	2010-11-16	83,580	$0.00	232,188	No	4	C	Indirect	See Footnote
Common Stock, Par Value $0.001	Acquisiton	2010-11-16	39,386	$9.00	271,574	No	4	P	Indirect	See Footnote
Common Stock, Par Value $0.001	Acquisiton	2010-11-16	64,612	$0.00	64,612	No	4	C	Indirect	See Footnote
Common Stock, Par Value $0.001	Acquisiton	2010-11-16	36,339	$0.00	100,951	No	4	C	Indirect	See Footnote
Common Stock, Par Value $0.001	Acquisiton	2010-11-16	17,124	$9.00	118,075	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series D Preferred Stock	Disposition	2010-11-16	2,061,134	$0.00	2,061,134	$0.00
Common Stock	Series D Preferred Stock	Disposition	2010-11-16	148,608	$0.00	148,608	$0.00
Common Stock	Series D Preferred Stock	Disposition	2010-11-16	64,612	$0.00	64,612	$0.00
Common Stock	Series E Preferred Stock	Disposition	2010-11-16	1,159,218	$0.00	1,159,218	$0.00
Common Stock	Series E Preferred Stock	Disposition	2010-01-16	83,580	$0.00	83,580	$0.00
Common Stock	Series E Preferred Stock	Disposition	2010-01-16	36,339	$0.00	36,339	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series D and Series E Preferred Stock will automatically convert on a 1 for 1 basis into common stock upon the closing of the Issuer's initial public offering.
The shares are owned by Essex Woodlands Health Ventures Fund VIII, L.P. ("Essex Woodlands Ventures Fund"). Essex Woodlands Health Ventures VIII, L.P. ("Essex Ventures L.P.") serves as the general partner of Essex Woodlands Ventures Fund and Essex Woodlands Health Ventures VIII, LLC ("Essex Ventures LLC") serves as the general partner of Essex Ventures L.P. James Currie, Ron Eastman, Jeff Himawan, Ph.D., Guido Neels, Martin Sutter, Immanuel Thangaraj, Petri Vainio, M.D., Ph.D. and Steve Wiggins are managing directors of Essex Ventures LLC and are deemed to have shared voting and investment power over the shares held by Essex Woodlands Ventures Fund. Each of the managing directors disclaims beneficial ownership of the shares held by Essex Woodlands Ventures Fund except to the extent of any pecuniary interest therein.
The shares are owned by Essex Woodlands Health Ventures Fund VIII A, L.P. ("Essex Woodlands Fund A"). Essex Ventures L.P. serves as the general partner of Essex Woodlands Fund A and Essex Ventures LLC serves as the general partner of Essex Ventures L.P. James Currie, Ron Eastman, Jeff Himawan, Ph.D., Guido Neels, Martin Sutter, Immanuel Thangaraj, Petri Yaino, M.D., Ph.D. and Steve Wiggans are managing directors of Essex Ventures LLC and are deemed to have shared voting and investment power over the shares held by Essex Woodlands Fund A. Each of the managing directors disclaims beneficial ownership of the shares held by Essex Woodlands Fund A except to the extent of any pecuniary interest therein.
The shares are owned by Essex Woodlands Health Ventures Fund VIII B, L.P. ("Essex Woodlands Fund B"). Essex Ventures L.P. serves as the general partner of Essex Woodlands Fund B and Essex Ventures LLC serves as the general partner of Essex Ventures L.P. James Currie, Ron Eastman, Jeff Himawan, Ph.D., Guido Neels, Martin Sutter, Immanuel Thangaraj, Petri Yaino, M.D., Ph.D. and Steve Wiggans are managing directors of Essex Ventures LLC and are deemed to have shared voting and investment power over the shares held by Essex Woodlands Fund B. Each of the managing directors disclaims beneficial ownership of the shares held by Essex Woodlands Fund B except to the extent of any pecuniary interest therein.
The securities are immediately convertible.
The expiration date is not relevant to the conversion of these securities.
Essex Woodlands Ventures Fund purchased an additional 546,268 shares of Issuer's common stock in connection with the initial public offering at the offering price of $9.00 per share.
Essex Woodlands Fund A purchased an additional 39,386 shares of Issuer's common stock in connection with the initial public offering at the offering price of $9.00 per share.
Essex Woodlands Fund B purchased an additional 17,124 shares of Issuer's common stock in connection with the initial public offering at the offering price of $9.00 per share.